These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 624843)

  • 21. C3 binds with similar efficiency to Fab and Fc regions of IgG immune aggregates.
    Antón LC; Ruiz S; Barrio E; Marqués G; Sánchez A; Vivanco F
    Eur J Immunol; 1994 Mar; 24(3):599-604. PubMed ID: 8125130
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanism of action of blocking immunoglobulin G for Neisseria gonorrhoeae.
    Joiner KA; Scales R; Warren KA; Frank MM; Rice PA
    J Clin Invest; 1985 Nov; 76(5):1765-72. PubMed ID: 3932472
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular composition of complement-solubilized complexes and their fate in vivo.
    Malasit P; Bartolotti SR; Humphrey JH
    Immunology; 1983 Apr; 48(4):779-89. PubMed ID: 6832806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complement fixation by solid phase immune complexes. Reduced capacity in SLE sera.
    Baatrup G; Jonsson H; Sjöholm A; Sturfelt G; Svehag SE
    J Clin Lab Immunol; 1988 Jun; 26(2):73-9. PubMed ID: 3264027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Localization of the membrane attack complex (MAC) in experimental immune complex glomerulonephritis.
    Koffler D; Biesecker G; Noble B; Andres GA; Martinez-Hernandez A
    J Exp Med; 1983 Jun; 157(6):1885-905. PubMed ID: 6343549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for the involvement of the Ss protein of the mouse in the hemolytic complement system.
    Hansen TH; Shin HS; Shreffler DC
    J Exp Med; 1975 May; 141(5):1216-20. PubMed ID: 805206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of the guinea pig alternative complement pathway by mouse IgA immune complexes.
    Pfaffenbach G; Lamm ME; Gigli I
    J Exp Med; 1982 Jan; 155(1):231-47. PubMed ID: 7054357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-F(ab')2 antibodies that interfere with interpretation of the anti-C3 assay for immune complexes in children with rheumatic diseases.
    Olds LC; Miller JJ
    Arthritis Rheum; 1984 Mar; 27(3):330-6. PubMed ID: 6704194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human monocyte spreading induced by activated factor B of the complement alternative pathway: differential effects of Fab' and F(ab')2 antibody fragments directed to C5, C6, and C7.
    Sundsmo JS; Götze O
    Cell Immunol; 1983 Apr; 77(1):176-86. PubMed ID: 6601526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monoclonal rheumatoid factor-IgG immune complexes. Poor fixation of opsonic C4 and C3 despite efficient complement activation.
    Ng YC; Peters DK; Walport MJ
    Arthritis Rheum; 1988 Jan; 31(1):99-107. PubMed ID: 3345233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The specific in vitro antibody-mediated retention of bovine serum albumin by porcine hyaline articular cartilage.
    Aston WP; Ward TL; Cooke TD
    Clin Exp Immunol; 1983 May; 52(2):280-6. PubMed ID: 6861375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Membrane receptors on neutrophils.
    Henson PM
    Immunol Commun; 1976; 5(9):757-74. PubMed ID: 799616
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fc-mediated immune precipitation. IV. Antigen dependency and specificity.
    Møller NP; Pedersen TS
    Immunology; 1983 Mar; 48(3):477-88. PubMed ID: 6186597
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BSA-anti-BSA immune complexes formed in the presence of human complement do not bind to autologous red blood cells.
    Varga L; Thiry E; Füst G
    Immunology; 1988 Jul; 64(3):381-4. PubMed ID: 3410490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determination of complement activating circulating immune complexes and an example for antigen specific immune complex assays.
    Krapf F; Fuchs C; Herrmann M; Hoferichter S; Kalden JR
    J Clin Lab Immunol; 1986 Dec; 21(4):183-7. PubMed ID: 3550093
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A quantitative analysis of the interactions of antipneumococcal antibody and complement in experimental pneumococcal bacteremia.
    Brown EJ; Hosea SW; Hammer CH; Burch CG; Frank MM
    J Clin Invest; 1982 Jan; 69(1):85-98. PubMed ID: 7054244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitation of circulating immune complexes in human serum by the Raji cell and F(ab')2 anti-C3 micro enzyme immunoassays.
    Jordan SC; Gautier E; Sakai R; Bahn L
    J Immunol Methods; 1985 Nov; 83(2):363-70. PubMed ID: 3902980
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Demonstration of binding sites for IgG Fc and the third complement component (C3) on isolated hepatocytes.
    Hopf U; Meyer zum Büschenfelde KH; Dierich MP
    J Immunol; 1976 Aug; 117(2):639-45. PubMed ID: 781134
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of antibody and complement in the immune clearance and destruction of erythrocytes. II. Molecular nature of IgG and IgM complement-fixing sites and effects of their interaction with serum.
    Schreiber AD; Frank MM
    J Clin Invest; 1972 Mar; 51(3):583-9. PubMed ID: 4622104
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative analyses of the relationship between C3 consumption, C3b capture, and immune adherence of complement-fixing antibody/DNA immune complexes.
    Edberg JC; Tosic L; Wright EL; Sutherland WM; Taylor RP
    J Immunol; 1988 Dec; 141(12):4258-65. PubMed ID: 3198918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.